in-house trial
Can Rapamycin Improve Gum Health?
Could Rapamycin support oral health as part of healthy aging? Explore how mTOR, gum disease, and early research may connect periodontal health to longevity.
Commercial Biobanking: What It Is and Why It Matters
Commercial biobanking stores your biological samples long-term for future research. Learn what it means for your longevity goals.
Sleep, Aging & Our Observational Trial
Our Observational Sleep for Longevity Trial is now in analysis, exploring how sleep patterns connect to biological age.
AgelessRx + XPRIZE Healthspan Semi-Finals: Our 90-Day Trial Findings
AgelessRx's XPRIZE Healthspan 90-day pilot measured biological aging markers in a cohort of adults. Explore the key findings from our semi-finals longevity protocol
Canagliflozin as a Longevity Therapy: AgelessRx Trial Findings
A closer look at our Canagliflozin pilot trial, including the study design, metabolic findings, glucose response, and tolerability in healthy adults.
Low Dose Naltrexone for Healthspan: What Our Real-World Study Found
Explore how Low Dose Naltrexone may target inflammaging and support healthspan, based on real-world findings from 5,500 participants.
AgelessRx PEARL Trial: Rapamycin & LDN Bone Density Findings
Explore PEARL trial findings on Rapamycin, Low Dose Naltrexone, and bone density, including a notable case report, potential mechanisms, safety considerations, and the need for…
What The AgelessRx Rapamycin Study Revealed About Bioavailability
Fat intake, gut microbiome composition, and enzyme activity may all influence Rapamycin absorption. See what our study revealed.
Understanding Our SF-36 Quality of Life Study
Curious about the SF-36 quality of life study? Discover what this validated health survey measures and what our longevity research found.
LDN and NAD+ for Long COVID Fatigue: AgelessRx Trial Findings
Low Dose Naltrexone and NAD+ were tested together for Long COVID fatigue in our trial. Learn what the results showed and why the combination worked.
Acarbose Longevity Research: AgelessRx Trial Data
Our Research Team tracked Acarbose as a longevity intervention in a pilot trial. See biomarker findings, glucose data, and tolerability results.
Microdosing GLP-1 for Longevity: What Our Trial Is Studying
Explore how Microdosing Semaglutide may support metabolic health, inflammation, and longevity, including what our GLP-1 trial is studying.